13F-HR filed by Altium Capital Management LLC
Altium Capital Management LLC filed this 13F-HR for the quarter ended 2021-03-31, filed 2021-05-06, with 124 holding rows worth $360,252,000.
- Accession
- 0001387131-21-005365
- Filer
- CIK 1746382
- Filed
- 2021-05-06
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2021
A holdings report, 124 entries on the cover page, a total value of $360,252,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $360,252,000 with VALUE read as thousands by filing date, 13F file number 028-20820. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CURIS INC | 231269200 | COM | 772,009 | $8,739,000 | thousands by filing date | |
| VERRICA PHARMACEUTICALS INC | 92511W108 | COM | 562,954 | $8,529,000 | thousands by filing date | |
| BIORA THERAPEUTICS INC | 74319F107 | COM | 1,748,252 | $8,322,000 | thousands by filing date | |
| CHARDAN HEALTHCR ACQSTN 2 CO | 15957T107 | COM | 753,374 | $7,571,000 | thousands by filing date | |
| ESSA PHARMA INC | 29668H708 | COM NEW | 230,063 | $6,683,000 | thousands by filing date | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 548,225 | $6,513,000 | thousands by filing date | |
| VERASTEM INC | 92337C104 | COM | 2,573,222 | $6,356,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 238,354 | $6,173,000 | thousands by filing date | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 1,573,389 | $6,042,000 | thousands by filing date | |
| LANTHEUS HLDGS INC | 516544103 | COM | 275,066 | $5,878,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 253,448 | $5,667,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 902,633 | $5,578,000 | thousands by filing date | |
| CAREDX INC | 14167L103 | COM | 81,284 | $5,535,000 | thousands by filing date | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 361,930 | $5,530,000 | thousands by filing date | |
| INSULET CORP COM | 45784P101 | Stock | 21,000 | $5,479,000 | thousands by filing date | |
| SIENTRA INC | 82621J105 | COM | 739,045 | $5,388,000 | thousands by filing date | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 326,174 | $5,313,000 | thousands by filing date | |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 408,908 | $5,310,000 | thousands by filing date | |
| NEVRO CORP | 64157F103 | COM | 37,900 | $5,287,000 | thousands by filing date | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 210,484 | $5,256,000 | thousands by filing date | |
| MYRIAD GENETICS INC | 62855J104 | COM | 171,785 | $5,231,000 | thousands by filing date | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 226,719 | $5,160,000 | thousands by filing date | |
| NOCTURNE ACQUISITION CORP | G6580S122 | UNIT 02/25/2026 | 500,000 | $5,000,000 | thousands by filing date | |
| CELSION CORP | 15117N503 | COM PAR NEW | 3,496,154 | $4,825,000 | thousands by filing date | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 223,000 | $4,743,000 | thousands by filing date | |
| TCR2 THERAPEUTICS INC | 87808K106 | COM | 209,130 | $4,618,000 | thousands by filing date | |
| FORTE BIOSCIENCES INC | 34962G109 | COM | 134,542 | $4,611,000 | thousands by filing date | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 1,250,000 | $4,213,000 | thousands by filing date | |
| HARPOON THERAPEUTICS INC | 41358P106 | COM | 199,607 | $4,176,000 | thousands by filing date | |
| EUCRATES BIOMEDICAL ACQU COR | G3141W114 | UNIT 10/23/2027 | 400,000 | $4,005,000 | thousands by filing date | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 440,589 | $3,983,000 | thousands by filing date | |
| ARYA SCIENCES ACQUISITION CO | G3166W106 | COM CL A | 286,383 | $3,946,000 | thousands by filing date | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 178,600 | $3,895,000 | thousands by filing date | |
| IMMATICS N.V | N44445109 | SHS | 344,558 | $3,862,000 | thousands by filing date | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 110,254 | $3,755,000 | thousands by filing date | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 483,041 | $3,734,000 | thousands by filing date | |
| CONSTELLATION PHARMACEUTICALS INC. | 210373106 | Common Stock | 158,733 | $3,713,000 | thousands by filing date | |
| IMMUNOVANT INC | 45258J102 | COM | 229,622 | $3,683,000 | thousands by filing date | |
| TFF PHARMACEUTICALS INC | 87241J104 | COM | 269,691 | $3,660,000 | thousands by filing date | |
| ALPHA HEALTHCARE ACQUISTN CO | 020751202 | UNIT 10/01/2023 | 275,000 | $3,436,000 | thousands by filing date | |
| NEWAGE INC | 650194103 | COMMON STOCK | 1,198,150 | $3,427,000 | thousands by filing date | |
| GLAUKOS CORP COM | 377322102 | Stock | 40,800 | $3,424,000 | thousands by filing date | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 113,962 | $3,297,000 | thousands by filing date | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 128,130 | $3,292,000 | thousands by filing date | |
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 205,799 | $3,198,000 | thousands by filing date | |
| INFINITY PHARMACEUTICALS INC | 45665G303 | COM | 972,327 | $3,141,000 | thousands by filing date | |
| ILLUMINA INC | 452327109 | COM | 8,000 | $3,072,000 | thousands by filing date | |
| Inflarx Nv | N44821101 | COM | 774,600 | $3,021,000 | thousands by filing date | |
| GLOBUS MED INC CL A | 379577208 | Stock | 48,862 | $3,013,000 | thousands by filing date | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 88,326 | $2,997,000 | thousands by filing date | |
| INTERSECT ENT INC | 46071F103 | COM | 141,856 | $2,962,000 | thousands by filing date | |
| MORPHIC HLDG INC | 61775R105 | COM | 46,541 | $2,945,000 | thousands by filing date | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 289,316 | $2,939,000 | thousands by filing date | |
| NUVASIVE INC | 670704105 | COM | 43,133 | $2,828,000 | thousands by filing date | |
| GEMINI THERAPEUTICS INC | 36870G105 | CMN | 203,995 | $2,764,000 | thousands by filing date | |
| PHASEBIO PHARMACEUTICALS INC | 717224109 | COM | 775,000 | $2,682,000 | thousands by filing date | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 166,636 | $2,588,000 | thousands by filing date | |
| CONFORMIS INC | 20717E101 | COM | 2,608,875 | $2,583,000 | thousands by filing date | |
| MOONLAKE IMMUNOTHERAPEUTICS | G4444C102 | COM | 250,000 | $2,550,000 | thousands by filing date | |
| PROFOUND MED CORP | 74319B502 | COM NEW | 126,427 | $2,546,000 | thousands by filing date | |
| TURMERIC ACQUISITION CORP | G9127T116 | UNT | 254,000 | $2,540,000 | thousands by filing date | |
| LIFESCI ACQUISITION II CORP | 53229E103 | COM | 250,000 | $2,535,000 | thousands by filing date | |
| CONSONANCE HFW ACQUISITION C | G2445M129 | UNIT 99/99/9999 | 250,000 | $2,440,000 | thousands by filing date | |
| SARISSA CAPITAL ACQUISITN CO | G7823W128 | UNIT 10/23/2027 | 225,000 | $2,437,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 103,262 | $2,402,000 | thousands by filing date | |
| OPUS GENETICS INC | 67577R102 | COMMON STOCK | 397,036 | $2,306,000 | thousands by filing date | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 398,997 | $2,238,000 | thousands by filing date | |
| MEI PHARMA INC | 55279B202 | COM NEW | 638,083 | $2,189,000 | thousands by filing date | |
| VAREX IMAGING CORP | 92214X106 | COMMON STOCK | 105,727 | $2,166,000 | thousands by filing date | |
| ADAMAS PHARMACEUTICALS INC | 00548A106 | COM | 450,000 | $2,160,000 | thousands by filing date | |
| SERES THERAPEUTICS INC | 81750R102 | COM | 104,626 | $2,154,000 | thousands by filing date | |
| AEGLEA BIOTHERAPEUTICS INC | 00773J103 | COM | 267,753 | $2,121,000 | thousands by filing date | |
| PYXIS TANKERS INC | Y71726106 | COM | 2,035,793 | $2,097,000 | thousands by filing date | |
| CALITHERA BIOSCIENCES INC COM NEW | 13089P101 | Stock | 853,902 | $2,066,000 | thousands by filing date | |
| HEALTHCOR CATALIO ACQU CORP | G44125105 | CL A SHS | 200,000 | $2,000,000 | thousands by filing date | |
| COHERUS ONCOLOGY INC | 19249H103 | COM | 136,623 | $1,996,000 | thousands by filing date | |
| PARDES BIOSCIENCES INC COM | 30318F100 | Stock | 200,000 | $1,992,000 | thousands by filing date | |
| JIYA ACQUISITION CORP | 47760M102 | CMN | 200,000 | $1,968,000 | thousands by filing date | |
| YUMANITY THERAPEUTICS INC | 98872L102 | COM | 108,695 | $1,967,000 | thousands by filing date | |
| DIANTHUS THERAPEUTICS INC COM | 55910K108 | Stock | 164,381 | $1,946,000 | thousands by filing date | |
| LANDCADIA HOLDINGS III INC | 51476H100 | COM CL A | 192,314 | $1,925,000 | thousands by filing date | |
| HAEMONETICS CORP MASS COM | 405024100 | Stock | 17,044 | $1,892,000 | thousands by filing date | |
| ACE Convergence Acquisition Corp | G0083D120 | COM | 189,000 | $1,884,000 | thousands by filing date | |
| CASTLE BIOSCIENCES INC | 14843C105 | COMMON STOCK | 27,365 | $1,873,000 | thousands by filing date | |
| ADICET BIO INC | 007002108 | COM | 142,289 | $1,861,000 | thousands by filing date | |
| SALARIUS PHARMACEUTICALS INC | 79400X107 | COM NEW | 1,250,110 | $1,850,000 | thousands by filing date | |
| EIGER BIOPHARMACEUTICALS INC | 28249U105 | COM | 197,500 | $1,748,000 | thousands by filing date | |
| CTI BIOPHARMA CORP | 12648L601 | COM | 588,992 | $1,714,000 | thousands by filing date | |
| NEURONETICS INC | 64131A105 | COM | 137,500 | $1,701,000 | thousands by filing date | |
| BRAINSWAY LTD | 10501L106 | CMN | 179,506 | $1,621,000 | thousands by filing date | |
| EXAGEN INC | 30068X103 | COM | 86,475 | $1,513,000 | thousands by filing date | |
| CM LIFE SCIENCES INC | 18978W109 | COM CL A | 100,000 | $1,489,000 | thousands by filing date | |
| ONCTERNAL THERAPEUTICS INC | 68236P107 | COM | 176,287 | $1,467,000 | thousands by filing date | |
| VALLON PHARMACEUTICALS INC | 92023M101 | COM | 300,000 | $1,392,000 | thousands by filing date | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 93,261 | $1,363,000 | thousands by filing date | |
| BCTG ACQUISITION CORP | 05492W103 | COM | 120,000 | $1,334,000 | thousands by filing date | |
| TAILWIND ACQUISITION CORP | 87403Q102 | COM CL A | 128,414 | $1,274,000 | thousands by filing date | |
| Viewra, Inc | 92672L107 | COM | 289,114 | $1,258,000 | thousands by filing date | |
| GIGCAPITAL4 INC | 37518G200 | UNIT 99/99/9999 | 125,000 | $1,234,000 | thousands by filing date | |
| BCLS ACQUISITION CORP | G0904B105 | CMN | 100,000 | $1,057,000 | thousands by filing date | |
| FAT BRANDS INC | 30258N121 | *W EXP 07/16/202 | 300,000 | $1,056,000 | thousands by filing date | |
| Roth Ch Acquisition II Co | 778673202 | Unit | 100,000 | $1,054,000 | thousands by filing date | |
| ARYA SCIENCES ACQU CORP IV | G31659108 | COM | 100,000 | $1,047,000 | thousands by filing date | |
| AJAX I | G0190X100 | COM | 100,000 | $1,026,000 | thousands by filing date | |
| QELL ACQUISITION CORP | G7307X105 | CL A | 100,000 | $1,018,000 | thousands by filing date | |
| SUPERNOVA PARTNERS ACQUISITI | 86846V108 | COM CL A | 100,000 | $1,011,000 | thousands by filing date | |
| MOTIVE CAPITAL CORP | G6293A103 | SHS CL A | 102,099 | $1,001,000 | thousands by filing date | |
| FIRSTMARK HORIZON ACQUISITIO | 33765Y101 | CL A COM | 100,000 | $1,000,000 | thousands by filing date | |
| CITIC CAPITAL ACQUISITION CO | G21513109 | COM CL A | 100,000 | $1,000,000 | thousands by filing date | |
| OMEGA ALPHA SPAC | G6749V107 | CL A | 100,000 | $990,000 | thousands by filing date | |
| SYROS PHARMACEUTICALS INC | 87184Q107 | COM | 126,702 | $948,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 45,013 | $927,000 | thousands by filing date | |
| VINCERX PHARMA INC | 92731L114 | *W EXP 12/24/202 | 215,250 | $870,000 | thousands by filing date | |
| CHARDAN HEALTHCR ACQSTN 2 CO | 15957T115 | *W EXP 03/05/202 | 731,561 | $688,000 | thousands by filing date | |
| BRIACELL THERAPEUTICS CORP | 10778Y112 | *W EXP 02/26/202 | 500,000 | $535,000 | thousands by filing date | |
| CATALYST BIOSCIENCES INC | 14888D208 | COM | 89,930 | $453,000 | thousands by filing date | |
| VERB TECHNOLOGY CO INC | 92337U104 | COM | 281,173 | $394,000 | thousands by filing date | |
| CM LIFE SCIENCES INC | 18978W117 | *W EXP 09/04/202 | 66,666 | $345,000 | thousands by filing date | |
| IMMATICS N.V | N44445117 | *W EXP 07/01/202 | 97,467 | $288,000 | thousands by filing date | |
| GENPREX INC | 372446104 | COM | 60,909 | $263,000 | thousands by filing date | |
| EVAXION BIOTECH A S | 29970R105 | ADR | 24,725 | $146,000 | thousands by filing date | |
| AMPLITUDE HLTHCRE AQUSTIN CO | 03212A113 | *W EXP 12/01/202 | 162,500 | $133,000 | thousands by filing date | |
| HEALTH SCIENCES ACQ CORP 2 | G4411D109 | ORD SHS | 10,000 | $112,000 | thousands by filing date | |
| SHAPEWAYS HOLDIN | G3770A110 | EQUITY WRT | 200,000 | $110,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001387131-21-005365 | this filing | 2021-05-06 | acceptance time not in the bulk data set |